Showing results (101-110 of 120) with videos related to
Sort By:
Pageof 12
Pharmacoepidemiology and Drug Safety|May 6, 2025
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United StatesPatricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.Journal of Biomedical Informatics|October 1, 2018
A novel depth estimation algorithm of chest compression for feedback of high-quality cardiopulmonary resuscitation based on a smartwatchTsung-Chien Lu, Yi Chen, Te-Wei Ho, et al.Resuscitation|May 13, 2019
Using a smartwatch with real-time feedback improves the delivery of high-quality cardiopulmonary resuscitation by healthcare professionalsTsung-Chien Lu, Yao-Ting Chang, Te-Wei Ho, et al.Journal of the American Medical Informatics Association : JAMIA|October 30, 2018
AMIA Board White Paper: AMIA 2017 core competencies for applied health informatics education at the master's degree levelAnnette L Valenta, Eta S Berner, Suzanne A Boren, et al.Intensive Care Medicine|October 3, 2019
Randomised evaluation of active control of temperature versus ordinary temperature management (REACTOR) trialPaul J Young, Michael J Bailey, Frances Bass, et al.Applied Clinical Informatics|June 22, 2017
Solving Interoperability in Translational Health. Perspectives of Students from the International Partnership in Health Informatics Education (IPHIE) 2016 Master ClassAnne M Turner, Julio C Facelli, Monique Jaspers, et al.Brain : a Journal of Neurology|May 27, 2017
ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolismRadha Desai, Ann E Frazier, Romina Durigon, et al.Intensive Care Medicine|July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19, Anthony C Gordon, Paul R Mouncey, et al.Pageof 12